Integrating vaccines and contraception for postpartum women
Postpartum Integration of Vaccines and Contraception Trial
NA · University of California, San Diego · NCT05732142
This study tests whether combining postpartum birth control with baby vaccination services can help new mothers in rural India use contraception more effectively.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 286 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of California, San Diego (other) |
| Locations | 2 sites (La Jolla, California and 1 other locations) |
| Trial ID | NCT05732142 on ClinicalTrials.gov |
What this trial studies
This study examines the implementation of a gender-transformative family planning program that integrates postpartum contraception with community-based infant vaccination services in rural India. It aims to evaluate the effectiveness of this approach in increasing postpartum contraceptive use among women who have recently given birth. By leveraging existing health programs, the study seeks to address barriers to family planning care and improve maternal and infant health outcomes in a low-resource setting. The intervention will be delivered during routine vaccination sessions, targeting postpartum women who attend these services.
Who should consider this trial
Good fit: Ideal candidates for this study are postpartum women who delivered a baby within the past 12 weeks, speak Marathi, and reside in rural Maharashtra.
Not a fit: Patients who are currently pregnant or have undergone sterilization, hysterectomy, or immediate postpartum IUD placement will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase postpartum contraceptive use and improve maternal and infant health outcomes in rural communities.
How similar studies have performed: Other studies have shown success in integrating family planning services with vaccination programs, but this specific approach targeting postpartum women is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postpartum women who delivered a baby within the past 12 weeks * Speak Marathi * Reside in rural Maharashtra * Did not undergo sterilization, hysterectomy or immediate postpartum intrauterine device (IUD) placement Exclusion Criteria: * Currently pregnant
Where this trial is running
La Jolla, California and 1 other locations
- University of California, San Diego — La Jolla, California, United States (ACTIVE_NOT_RECRUITING)
- Junnar Taluka — Pune, Maharashtra, India (RECRUITING)
Study contacts
- Principal investigator: Sarah Averbach, MD, MAS — University of California, San Diego
- Study coordinator: Gennifer Kully, MSc
- Email: gkully@health.ucsd.edu
- Phone: 858-329-4464
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Contraception, Gender Equity, Family Planning, Infant Vaccination, Linked Care, India